European Commission logo
Deutsch Deutsch
CORDIS - Forschungsergebnisse der EU
CORDIS
Inhalt archiviert am 2024-05-24

The impact of treatment with acetylcholinesterase inhibitors on Europeans with Alzheimers disease

Ziel

AChe I have been shown to afford modest benefits on cognition in AD patients. A systematic review by the Cochrane Collaboration states "the practical importance of these changes to patients is unclear" This study's primary objective is to find clinical evidence for the global efficacy of AChE I. The secondary aim is to develop a picture of the natural history of AD. These outcomes will provide a fundamental insight into the progression and treatment of AD aiding the formulation of European guidelines. This is a prospective 2 year observational study which co-ordinates the centralisation of patient data available within the individual centres. It does not require any modification in prescribing practice of participating centres. Patients will be recruited into either a treated or non-treated patient group and reviewed 6 monthly. The primary outcome measure is a deterioration of one level on the clinical dementia rating scale.

Wissenschaftliches Gebiet

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

CON - Coordination of research actions

Koordinator

CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
EU-Beitrag
Keine Daten
Adresse
Av. de Casselardit, 170
31300 TOULOUSE
Frankreich

Auf der Karte ansehen
Gesamtkosten
Keine Daten

Beteiligte (30)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 13 Juni 2006

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/QLK6-CT-2002-02645/de

European Union, 2024